Billions and Billions

Are we living better, longer, thanks to increasingly sensitive cancer screening programs? Do tireless efforts to predict and prevent possible complications of chronic diseases make us healthier and happier? Is it right to perform surgeries and remove healthy tissues under the pretext of improving our quality of life, just in case? Robert Aronowitz, author of Risk Medicine, argues that the answer to these questions is not always positive.

Revealing that today's healthcare system and clinical practices focus on risk reduction and risk control in many aspects, Aronowitz examines the transformations in the healthcare industry over the last three to four years that have led doctors to reduce risks rather than relieving symptoms or curing diseases. He argues that this transformation is driven in part by pharmaceutical companies that want to market their products to a larger percentage of the population who are at risk for a particular disease, rather than to the small percentage who actually suffer from it. Drawing on examples such as cancer screening programs and various preventive vaccines, the author claims that the main goal of many interventions today is to reduce fears and uncertainty.

Risk Medicine draws attention to modern medicine's obsession with risk, calling for tighter oversight of risk-reducing interventions and for the health sector to focus on treating and relieving the suffering of people suffering from diseases.

(From the Promotional Bulletin)

Dough Type: 2nd Dough

Number of Pages: 304

Size: 13.5 x 21

First Print Year: 2019

Number of Printings: 1st Edition

Language Turkish